Keyphrases
T Cell Receptor
100%
Gene Polymorphism
100%
Variable Genes
100%
Immune-related Adverse Events
100%
Checkpoint Blockade Immunotherapy
100%
Polymorphism
83%
Severe Immune-related Adverse Events
66%
Germ Cells
33%
Cancer Immunotherapy
33%
Amplicon
33%
Predictive Biomarker
33%
Complementarity-determining Region 3 (CDR3)
33%
Long Amplicon
33%
Next-generation Sequencing
16%
CDR1
16%
Cancer Treatment
16%
Peripheral Blood
16%
Autoimmune Disease
16%
Total RNA
16%
Life-threatening
16%
Principal Coordinate Analysis (PCoA)
16%
Multiplex PCR (mPCR)
16%
Beta Chain
16%
CDR2
16%
Ion Torrent
16%
T-cell Receptor β Chain
16%
K-means
16%
IrAE
16%
Immune Checkpoint Inhibitors
16%
Genome Assembly
16%
Repertoire Sequencing
16%
Haplotype Groups
16%
Immunology and Microbiology
Immunity
100%
T Cell Receptor
100%
Immunotherapy
100%
DNA Polymorphism
100%
Haplotype
36%
Amplicon
36%
Allele
27%
Germ Cell
18%
Beta Chain
18%
Autoimmune Disease
9%
Multiplex Polymerase Chain Reaction
9%
Next Generation Sequencing
9%
Complementarity Determining Region
9%
Biochemistry, Genetics and Molecular Biology
Immunity
100%
T Cell Receptor
100%
Gene Polymorphism
100%
Haplotype
40%
Amplicon
40%
Allele
30%
Germline
20%
Germ Cell
20%
Beta Chain
20%
RNA
10%
Next Generation Sequencing
10%
Multiplex Polymerase Chain Reaction
10%
Complementarity Determining Region
10%
Principal Component Analysis
10%
Immune Checkpoints
10%